📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeted inhibition of gut bacterial ß-glucuronidase activity enhances anticancer drug efficacy. (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1918095117

PubMed Identifier: 32170007

Publication URI: http://europepmc.org/abstract/MED/32170007

Type: Journal Article/Review

Volume: 117

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 13

ISSN: 0027-8424